About

About Taichu Taichu Group is a biotechnology enterprise distinguished by its core competitive advantage in "CRO+CDMO integrated services", specializing in providing end-to-end technical solutions for global innovative drug development spanning from early-stage discovery through preclinical research. Headquartered at Life Bay Park in Shanghai's Lingang Special Area, the Group operates through five specialized platforms - Tachu Bio, AceMab Ltd, Tarlead, Taiji Bio, and Tachu (Shenzhen) - establishing a comprehensive service ecosystem that encompasses: Pre-Clinical Research Antibody Discovery and Design Biologics Development and Manufacturing Nucleic Acid Therapeutic Development and Drug Product Manufacturing Comprehensive Innovative Therapeutic Development Advisory Services Guided by its corporate philosophy of "Integrity, Scientific Rigor, and Client-Centric Excellence," Tachu Group is committed to streamlining R&D workflows and accelerating therapeutic advancement for global partners. The organization's synergistic service model bridges critical gaps between discovery and commercialization, reinforcing its position as a strategic enabler in the biopharmaceutical innovation value chain.